Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome

Circulation Journal

Volumn 75, Issue 4, 2011, Pages 927-931

  Chen, Li ^a   Wang, Li ^b   Sun, Jinghui ^c   Qin, Jiong ^a   Tang, Chaoshu ^b,d   Jin, Hongfang ^a   Du, Junbao ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Children; Metoprolol; Midodrine; Postural orthostatic tachycardia syndrome

Indexed keywords

METOPROLOL; MIDODRINE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; METOPROLOL; MIDODRINE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; SURVIVAL RATE;

EID: 79953656638     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0514     Document Type: Article

References (14)

1. Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: A concise guide to diagnosis and management. J Cardiovasc Electrophysiol 2006; 17: 108-112.
2. Stewart JM. Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS). J Pediatr 2004; 145: 725-730.
3. Kanjwal Y, Kosinski D, Grubb BP. The postural tachycardia syndrome: Definition, diagnosis and management. Pacing Clin Electrophysiol 2003; 26: 1747-1757.
4. Stewart JM, Munoz J, Weldon A. Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance. Circulation 2002; 106: 2946-2954.
5. Tanaka H, Fujita Y, Takenaka Y, Kajiwara S, Masutani S, Ishizaki Y, et al. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Ped Internat 2009; 51: 169-179.
6. Chen L, Du JB, Jin HF, Zhang QY, Li WZ, Wang L, et al. Effect of selective alpha1 receptor agonist in the treatment of children with postural orthostatic tachycardia syndrome. Zhonghua Er Ke Za Zhi 2008; 46: 688-691.
7. Chen L, Du JB, Zhang QY, Wang C, Du ZD, Wang HW, et al. A multicenter study on treatment of autonomous nerve-mediated syncope in children with beta-receptor blocker. Zhonghua Er Ke Za Zhi 2007; 45: 885-888.
8. Fujikawa T, Tochikubo O, Kura N, Kiyokura T, Shimada J, Umemura S. Measurement of hemodynamics during postural changes using a new wearable cephalic laser blood flowmeter. Circ J 2009; 73: 1950-1955.
9. Kario K. Orthostatic hypertension: A measure of blood pressure variation for predicting cardiovascular risk. Circ J 2009; 73: 1002-1007.
10. Takano H, Komuro I. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases. Circ J 2009; 73: 214-220.
11. Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CB, Driscoll SW, et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol 2009; 32: 234-238.
12. Nakagawa H, Kobayashi Y, Kikushima S, Shinohara M, Obara C, Zinbo Y, et al. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing. Jpn Circ J 1998; 62: 727-732.
13. Abe H, Nagatomo T, Kohshi K, Numata T, Kikuchi K, Sonoda S, et al. Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome. J Cardiovasc Pharmacol 2000; 36: 79-82.
14. Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J 2008; 72: 293-298.